Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.

MLA

Paul, Mical, et al. “Beta-Lactam versus Beta-Lactam-Aminoglycoside Combination Therapy in Cancer Patients with Neutropenia.” The Cochrane Database of Systematic Reviews, no. 6, June 2013, p. CD003038. EBSCOhost, https://doi.org/10.1002/14651858.CD003038.pub2.

APA

Paul, M., Dickstein, Y., Schlesinger, A., Grozinsky-Glasberg, S., Soares-Weiser, K., & Leibovici, L. (2013). Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. The Cochrane Database of Systematic Reviews, 6, CD003038. https://doi.org/10.1002/14651858.CD003038.pub2

Chicago

Paul, Mical, Yaakov Dickstein, Agata Schlesinger, Simona Grozinsky-Glasberg, Karla Soares-Weiser, and Leonard Leibovici. 2013. “Beta-Lactam versus Beta-Lactam-Aminoglycoside Combination Therapy in Cancer Patients with Neutropenia.” The Cochrane Database of Systematic Reviews, no. 6 (June): CD003038. doi:10.1002/14651858.CD003038.pub2.